Argitalpenak (13) BASILIO COLLIGRIS argitalpenak

2017

  1. The role and therapeutic potential of melatonin in age-related ocular diseases

    Journal of Pineal Research, Vol. 63, Núm. 2

  2. Therapeutic inhibitors for the treatment of dry eye syndrome

    Expert Opinion on Pharmacotherapy, Vol. 18, Núm. 17, pp. 1855-1865

2014

  1. An update on dry eye disease molecular treatment: Advances in drug pipelines

    Expert Opinion on Pharmacotherapy, Vol. 15, Núm. 10, pp. 1371-1390

  2. Dry eye disease compounds currently under evaluation in clinical trials

    Anales de la Real Academia Nacional de Farmacia, Vol. 80, Núm. 1, pp. 151-178

  3. Recent developments on dry eye disease treatment compounds

    Saudi Journal of Ophthalmology, Vol. 28, Núm. 1, pp. 19-30

2013

  1. Contact lenses: Promising devices for ocular drug delivery

    Journal of Ocular Pharmacology and Therapeutics, Vol. 29, Núm. 2, pp. 189-199

  2. Recent patents on Achondroplasia: Latest research development

    Recent Patents on Regenerative Medicine, Vol. 3, Núm. 3, pp. 264-277

2012

  1. Ocular disorders and the utility of animal models in the discovery of melatoninergic drugs with therapeutic potential

    Expert Opinion on Drug Discovery, Vol. 7, Núm. 10, pp. 989-1001

  2. Potential role of Rho-associated protein kinase inhibitors for glaucoma treatment

    Recent Patents on Endocrine, Metabolic and Immune Drug Discovery, Vol. 6, Núm. 2, pp. 89-98

  3. Recent patents and developments in glaucoma biomarkers

    Recent Patents on Endocrine, Metabolic and Immune Drug Discovery, Vol. 6, Núm. 3, pp. 224-234

  4. Update in glaucoma medicinal chemistry: Emerging evidence for the importance of melatonin analogues

    Current Medicinal Chemistry, Vol. 19, Núm. 21, pp. 3508-3522